retatrutide side effects phase 2 trial Effects: What Clinical Trials Tell Us Retatrutide study sees significant weight

That's my experience,' she says in confessional

GLP-1 and Blood Sugar Regulation Beyond appetite, the most important physiological role of GLP-1 involves blood glucose control

Moreover, efpeglenatide therapy reduced the risk of CV disease by about 27% compared to the placebo in the Effect of Efpeglenatide on Cardiovascular Outcomes (AMPLITUDE-O) study [51]

Jos Morales, MD, a vascular neurologist and neurointerventional surgeon at Providence Saint Johns Health Center in Santa Monica, CA, also not involved in this review, told MNT that microglias effect on the neurovascular unit has been associated with dementia. He suggested that: [GLP-1 drugs] could potentially modulate inflammation to reduce the propensity for developing dementias such as Alzheimers disease, particularly in the setting of metabolic syndrome. Morales also explained that in people who have glycemia or type 2 diabetes, the inflammation of the blood-brain barrier can lead to progressive damage to the brain over longer periods. He noted that trials that combine neuroimaging techniques that measure the blood-brain barrier and GLP-1 treatment are needed and could prove that these drugs have neuroprotective benefits.

Gastrointestinal effects dominate the side effect profile

Every meal is designed to hit the glp-1 protein target even on days when appetite is minimal